BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1656027)

  • 1. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    Xu JY; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tail-flick inhibition induced by beta-endorphin administered intrathecally is mediated by activation of kappa- and mu-opioid receptors in the mouse.
    Tseng LF; Collins KA
    Eur J Pharmacol; 1992 Apr; 214(1):59-65. PubMed ID: 1316280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forebrain sites differentially sensitive to beta-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthesized rat.
    Tseng LF; Wang Q
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1028-36. PubMed ID: 1318368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
    Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
    J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S; Zhang Z; Patterson N; Gulati A
    Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Huh SO; Kim YH
    Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
    Suh HW; Song DK; Choi SR; Chung KM; Kim YH
    Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.